NOT-FD-23-004: Notice to update Award Budget for PAR-23-072 "FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)"

Notice to update Award Budget for PAR-23-072 "FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)"

Notice Number:

NOT-FD-23-004

Key Dates

Release Date:

January 6, 2023

Related Announcements

PAR-23-072 - FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)

Issued by

FOOD AND DRUG ADMINISTRATION (FDA)

Purpose

This Notice is to notify applicants that the Award Budget for the following FDA Centers/Offices have been changed for PAR-23-072 "FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)."

Award Budget

Application budgets need to reflect the actual needs of the proposed project and should not exceed the following in total costs (direct and indirect):

Application budgets submitted to the following FDA Centers/Offices for review and funding consideration may not exceed the following in total cost per year:

ORA: up to $100,000

**All funding consideration is based on the availability of funds**

Inquiries

Please direct all inquiries to:

Janelle Fundersburg
Office of Acquisitions & Grants Services (OAGS)
Food and Drug Administration
Email: Janelle.Fundersburg@fda.hhs.gov